Atrial fibrillation (AF) and heart failure (HF) are common cardiovascular conditions that
frequently coexist. Among patients with HF, more than one-half also have AF. Both are …

Heart failure with preserved ejection fraction (HFpEF) is highly prevalent and associated
with worse cardiovascular outcomes. The pathophysiology of HFpEF mostly relies on the …

Aims Patients with heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation
(AF) have worse clinical outcomes than those with sinus rhythm (SR). We aim to investigate …

A vast amount of now well‐established clinical and epidemiological data indicates a close,
interdependent, and symbiotic association between atrial fibrillation (AF) and heart failure …

Heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) have
emerged as major age-related epidemics within cardiology. Both conditions carry …

Background: The safety and efficacy of atrial fibrillation (AF) ablation in individuals with heart
failure (HF) with preserved ejection fraction (EF), particularly concerning the occurrence of …

Atrial fibrillation (AF) is the most common arrhythmia worldwide, with a prevalence of 3% in
the general adult population and 18% in those older than 85 years. 1 Furthermore, the …

Background Atrial fibrillation (AF) is common in patients with heart failure (HF). Real-world
data about long-term outcomes and rhythm control interventions use in AF patients with and …

Notwithstanding the recent success of sodium-glucose cotransporter 2 inhibitors and, in
selected patients, angiotensin receptor–neprilysin inhibitors for reducing HF hospitalizations …

Inflammation, fibrosis and metabolic stress critically promote heart failure with preserved
ejection fraction (HFpEF). Exposure to high-fat diet and nitric oxide synthase inhibitor N [w] …